SCHEMBL4489321

SCHEMBL4489321

CCC(=O)Nc1n[nH]c2cc(-c3ccc(C)cc3)ccc12

nearest known ligand 0.76

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 20/20 0.76
CYP1A2 P05177 4/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1461670 0.91 GSK3B (0.82) GSK3BCYP1A2
SCHEMBL4487680 0.90 GSK3B (0.84) GSK3BCYP1A2
SCHEMBL4483590 0.89 GSK3B (0.84) GSK3BCYP1A2
SCHEMBL4503195 0.88 GSK3B (0.73) GSK3BCYP1A2
SCHEMBL4497413 0.86 HDAC1 (0.73) GSK3B
SCHEMBL4488991 0.86 GSK3B (0.85) GSK3BCYP1A2
SCHEMBL4499397 0.85 GSK3B (0.70) GSK3B
SCHEMBL4483435 0.84 GSK3B (0.72) GSK3B
SCHEMBL4484280 0.84 AAK1 (0.80) GSK3B
SCHEMBL4486435 0.83 GSK3B (0.85) GSK3BCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632854-B2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2009-12-15 US claimed